Official Title
Study of the Etiology of Lymphopenia in Covid19 Viral Infection
Brief Summary

Study of the cause of lymphopenia in Covid19 viral infection will be done in 3 cohorts. First cohort will be patients asymptomatic or with mild symptoms. Second cohort will be patients with severe illness and admitted to ICU. Third cohort will be patients critically ill and on artificial ventilation.

Detailed Description

Each cohort will include 30 patients. Complete blood count in all patients will be done daily
in all patients. Bone marrow aspiration cytology will be done in some selected patients
especially those with lymphopenia less than 1000 per cubic mm.

Correlation of the degree of lymphopenia with the status of the patients will be done. Also
correlation will be done about the relation of recovery of lymphopenia and status of the
patients.

Completed
Lymphopenia

Diagnostic Test: Complete blood picture, bone marrow aspiration cytology

none except the regular routine investigations in such cases

Eligibility Criteria

Inclusion Criteria:

- Any patient admitted with the diagnosis of Covid19 viral infection

Exclusion Criteria:

- Any patient who died within one day of admission

Eligibility Gender
All
Eligibility Age
Minimum: N/A ~ Maximum: N/A
Countries
Egypt
Locations

National Cancer Institute Cairo University
Cairo, Egypt

Dr Medhat Khafagy
NCT Number
MeSH Terms
Lymphopenia